Klotho Neurosciences, Inc. (KLTOW) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 7.77M | 8.55M | 687.71K | 157.81K | 154.65K | 999.84K | 8.05K | 6.65K | 203.81K |
| Cash & Short-Term Investments | 7.35M | 8.43M | 565.87K | 63.74K | 50.9K | 845.34K | 8.05K | 2.81K | 146.33K |
| Cash Only | 7.35M | 8.43M | 565.87K | 63.74K | 50.9K | 845.34K | 8.05K | 2.81K | 146.33K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 339.25K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 2.3M | 2.3M | 2.3M | 2.3M | 2.31M | 2.31M | 19.58M | 2.19M | 57.81M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 2.3M | 2.3M | 2.3M | 2.3M | 2.31M | 2.31M | 0 | 2.19M | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 19.58M | 0 | 57.81M |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 10.07M | 10.85M | 2.99M | 2.46M | 2.46M | 3.31M | 19.59M | 2.19M | 58.02M |
| Asset Turnover | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 308.78% | 227.73% | -84.75% | 12.07% | -95.75% | - | - | - | - |
| Total Current Liabilities | 92.89K | 62.96K | 2.34M | 1.25M | 982.43K | 898.56K | 2.58M | 1.62M | 1.66M |
| Accounts Payable | 0 | 12.63K | 66.55K | 63.69K | 271.13K | 33.99K | 0 | 151.26K | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 1.77M | 271.75K | 151K | 31K | 0 | 1.47M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 92.89K | 0 | 22.1K | 0 | 0 | 15.06K | 1.93M | 0 | 1.06M |
| Current Ratio | 83.69x | 135.74x | 0.29x | 0.13x | 0.16x | 1.11x | 0.00x | 0.00x | 0.12x |
| Quick Ratio | 83.69x | 135.74x | 0.29x | 0.13x | 0.16x | 1.11x | 0.00x | 0.00x | 0.12x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 53K | 132.45K | 10.97K | 24.49K | 21.2K | 3.96M | 5.91M | 0 | 5.58M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 3.9M | 1.54M | 0 | 1.14M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 18.09K | 0 | 51.71K |
| Other Non-Current Liabilities | 53K | 132.45K | 10.97K | 24.49K | 21.2K | 62.22K | 4.35M | 0 | 4.39M |
| Total Liabilities | 145.89K | 195.41K | 2.35M | 1.27M | 1M | 4.86M | 8.5M | 1.62M | 7.24M |
| Total Debt | 0 | 0 | 1.77M | 271.75K | 151K | 3.93M | 1.54M | 1.47M | 1.14M |
| Net Debt | -7.35M | -8.43M | 1.2M | 208.01K | 100.11K | 3.09M | 1.53M | 1.46M | 993.67K |
| Debt / Equity | - | - | 2.77x | 0.23x | 0.10x | - | 0.14x | 2.57x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -1.57x | -1.08x | -2.86x | -6.24x | -63.86x | -26.26x | - | -7.03x | -6.07x |
| Total Equity | 9.93M | 10.65M | 638.71K | 1.19M | 1.46M | -1.55M | 11.09M | 571.72K | 50.77M |
| Equity Growth % | 579.68% | 786.51% | -94.24% | 107.33% | -97.12% | - | - | - | - |
| Book Value per Share | 0.17 | - | 0.02 | 0.04 | 0.09 | - | 0.73 | - | - |
| Total Shareholders' Equity | 9.93M | 10.65M | 638.71K | 1.19M | 1.46M | -1.55M | 11.09M | 571.72K | 50.77M |
| Common Stock | 7.03K | 5.27K | 2.85K | 2.71K | 306.45K | 306.03K | 18.82M | 1.51K | 57.21M |
| Retained Earnings | -19.79M | -16.89M | -12.8M | -10.56M | -8.5M | -5.54M | -7.73M | -3.92M | -6.44M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |